Past POI Projects

SPOCCS I and SPOCCS II

Our original work in China was a cross-sectional comparative trial that, for the first time, directly measured sensitivity and specificity of […]

SPOCCS III

A population-based study of women, aged 16 to 54 years, was conducted in 3 rural ( Xinjiang , Shanxi, and

SHENCCAST I

SHENCCAST I (The Shenzhen cervical cancer screening program I) was initiated as a collaborative effort between the provincial government of

SHENCCAST II

SHENZHEN CERVICAL CANCER SCREENING PROGRAM – II Between April, 2009 and April, 2010, a multi-site, a 10,000 women population-based cross-sectional

SHENCCAST III

Shenzhen Cervical Cancer Screening Trial III Using the residual stored DNA from the Cervista High Risk HPV assay used in

CHIMUST

1. Front Public Health. 2022 Nov 10;10:1010066. doi: 10.3389/fpubh.2022.1010066. eCollection 2022. Comparison of cycle threshold values of the Cobas HPV

CHICAPS

CHICAPS (Chinese Cervical Cancer Prevention Study) Over the past several years the focus of cervical cancer screening programs designed for

SEQHPV

With great progress in HPV assay development over the past 5-7 years, and especially PCR based assays, BGI Shenzhen (the

PERCAPS

The Peru Cervical Cancer Prevention Study PERCAPS was a 2 Phase pilot project funded through the Merck Investigator Initiated Studies

MECCS I

MEXICAN CERVICAL CANCER SCREENING STUDY Our work in Mexico initially involved the “The Mexican cervical cancer screening study” (MECCS I)

MECCS II & References

MEXICAN CERVICAL CANCER SCREENING STUDY II This project took place in the State of Michoacán Mexico. Enrollment was conduced from

Scroll to Top